Table 1.
Baseline Characteristics and Testing History of Each Racial Group
| White | Black | Asian | P | |
|---|---|---|---|---|
| Subjects, n | 1515 | 782 | 357 | — |
| Female, n (%) | 820 (54.1) | 507 (64.8) | 204 (57.1) | <0.001a |
| Age (y), mean ± SD | 61.7 ± 15.1 | 58.2 ± 14.4 | 51.6 ± 16.1 | <0.001b |
| ADI, mean ± SD | 2.46 ± 1.95 | 3.64 ± 2.08 | 2.55 ± 1.77 | <0.001b |
| Baseline MD (dB), median (Q1, Q3) | −2.48 (−7.21, −0.49) | −4.11 (−10.72, −1.35) | −2.59 (−6.66, −0.75) | <0.001c |
| Number of visits per subject, mean ± SD | 8.90 ± 9.36 | 9.74 ± 10.03 | 7.61 ± 7.35 | 0.001b |
| Frequency of VFT per subject, mean ± SD | 2.62 ± 1.90 | 2.41 ± 1.53 | 2.27 ± 1.45 | < 0.001b |
| VFT false positives, mean ± SD | 4.88 ± 6.13 | 5.55 ± 7.91 | 5.25 ± 6.43 | 0.070b |
| VFT false negatives, mean ± SD | 4.68 ± 6.45 | 6.14 ± 7.17 | 4.13 ± 5.64 | <0.001b |
| VFT fixation loss, mean ± SD | 26.43 ± 22.13 | 27.68 ± 22.36 | 25.08 ± 23.15 | 0.169b |
| VFT/DoS ratio, mean ± SD | 0.46 ± 0.29 | 0.42 ± 0.29 | 0.45 ± 0.28 | 0.007b |
| Frequency of OCT per subject, mean ± SD | 2.43 ± 2.09 | 2.08 ± 1.74 | 1.86 ± 1.71 | <0.001b |
| SLT, n (%) | 71 (4.69) | 25 (3.20) | 3 (0.84) | 0.002a |
| Glaucoma surgery, n (%) | 157 (10.36) | 98 (12.53) | 28 (7.84) | 0.050 |
a
Pearson's χ2 test.
b
ANOVA.
c
Kruskal–Wallis rank sum test.